Ruby Dhar et al. 2025. Is calorie restriction with sodium-glucose cotransporter 2 inhibitor dapagliflozin a better option for type 2 diabetes mellitus management?. Asian Journal of Medical Sciences. 16, 3 (Mar. 2025), 1–2.